Oct 8, 2026
The Future of HIV Prevention: How Long-Acting Therapies Are Reshaping Global Healthcare
Sep 15, 2026
Early Market Entry: How API Manufacturers Prepare for Patent Expirations
Aug 13, 2026
Oncology APIs: Supporting the Next Generation of Cancer Therapies
Jul 17, 2026
The Evolution of Drug Master Files (DMFs): Supporting Faster Global Approvals
Jun 22, 2026
Quality by Design (QbD): Building Quality into APIs from Day One
May 18, 2026
AI-Powered Process Development in Pharmaceuticals: Transforming the Future of API Manufacturing
Apr 25, 2026
Beyond Compliance: Sustainability as a Competitive Advantage in API Manufacturing
Mar 15, 2026
Continuous Manufacturing: The Next Frontier in API Production
Feb 25, 2026
Peptide APIs: Transforming the Future of Global Healthcare
Jan 4, 2026
Lenacapavir and Dr. Reddy’s: Advancing the Future of HIV Treatment and Prevention
Dec 13, 2025
Spray Drying: Advancing Pharmaceutical Performance Through Precision Engineering
Nov 16, 2025
Understanding DMF‑Quality APIs and Their Key Applications in Global Pharma
Oct 12, 2025
API Process Development: Turning Molecules into Manufacturable, Scalable, High-Quality APIs
Sep 9, 2025
Zero Liquid Discharge (ZLD) in Pharma API Manufacturing
Aug 14, 2025
FDA GMP Compliance for APIs Documentation, Validation, and Quality Systems
Jul 25, 2025
Development of Niche Products at Dr. Reddys API
Jun 6, 2025
Harnessing India's New Drug Development Capabilities for Global Impact
May 6, 2025
The Impact of Global Regulations on the Active Pharmaceutical Ingredient Industry
Apr 8, 2025
The Importance of Supply Chain Management and Dr. Reddy’s Excellence
Mar 5, 2025
Current Landscape of Cancer Treatment in India and Dr. Reddy's Role in Enhancing Care
Feb 10, 2025
Global Development Strategy for Generic Formulations and APIs
Jan 6, 2025
APIs for Emerging Markets: Opportunities and Challenges
Dec 15, 2024
Formulation Strategies and Pharmaceutical Analysis for Anti-diabetic APIs
Dec 2, 2024
API Quality Control Technologies & Strategies: Current Advancements for Benefiting Pharma Companies
Oct 9, 2024
A year of growth & Sustainability
Aug 30, 2024
Understanding Nitrosamines and GTI Issues in APIs: A Comprehensive Overview with Dr. Reddy's Perspective
Aug 28, 2024
Innovative Approaches to API Production in 2024: Shaping the Future of Pharma Companies
Jul 30, 2024
Continuous Manufacturing Process and Its Impact on Pharma Manufacturing
Jun 28, 2024
A Comparative Study on Naproxen Formulations
Jun 18, 2024
An effective strategy for the development of docetaxel
May 22, 2024
Preformulation Studies for Generic Omeprazole
May 15, 2024
A comparative study on enzalutamide Formulations
Apr 30, 2024
Navigating the Heart of Pharmaceuticals: An In-Depth Exploration of Active Pharmaceutical Ingredient Manufacturing for Essential Medicines
Apr 1, 2024
Presence of Organic Impurities in active pharmaceutical ingredients: An Overview
Mar 30, 2024
Strategies and Technologies for Enhancing Cost-Effectiveness in Active Pharmaceutical Ingredient (API) Production
Feb 29, 2024
Ensuring Drug Safety: Comprehensive Analysis of Active Pharmaceutical Ingredient Lists
Feb 28, 2024
Unravelling the Science: Pharmaceutical Compositions and Process of Levetiracetam API
Dec 30, 2022
Steps taken by Dr. Reddy's Laboratories in controlling the environmental risks and safety management in the manufacturing of APIs
Dec 7, 2022
Meeting the New Regulatory Requirements and Controlling of Nitrosamine Impurities in Sartan API Production
Sep 14, 2022
Effective Formulation Development Strategies for Poorly Soluble Active Pharmaceutical Ingredients
Sep 13, 2022
Reshaping the Pharmaceutical API Industry with Digital Transformation
Aug 2, 2022
7 Ways how Active Pharmaceutical Ingredients (APIs) Enable Indian Pharmaceutical Companies to Grow
Aug 2, 2022
How is the Indian Pharmaceutical industry gearing up for 2022-2023?
Apr 14, 2022
Impact of COVID-19 on Indian HPAPI industry
Apr 14, 2022
The synthesis of active pharmaceutical ingredients (APIs) using continuous flow chemistry
Sep 14, 2021
ANVISA Certification of GMP Pharmaceutical Ingredients for 61 of Dr Reddy’s APIs
Jul 7, 2021
Managing the Product Life Cycle: Naproxen API and formulations
May 27, 2021
Understanding Active Pharmaceutical Ingredients: CPHI talk by Dr. Ramani Susarla
Mar 31, 2021
EMA Nitrosamine Guidance – Deadline March 31, 2021
Nov 26, 2020
Patient centricity and supply chain security in 2021 - Rajesh Sadanandan speaks on CPhI Pharma Trends 2021
Nov 19, 2020
Dr. Reddy's research publication on simultaneous automated image analysis and Raman spectroscopy of powders at an individual particle level
Sep 14, 2020
A Paradigm Shift that Is Here to Stay - Sauri Gudlavalleti speaks to CME Manager on COVID-19 response
Sep 7, 2020
A Year of Challenge and Opportunity - Deepak Sapra, Global Head of PSAI speaks to The Medicine Maker
Sep 2, 2020
COVID-19 and What’s Next for API Sourcing?
Aug 25, 2020
Indian healthcare reform offers thriving pharmaceutical market opportunities: Interview with Deepak Sapra
Jun 1, 2020
Dr. Reddy’s is improving supply chain performance for Pregabalin API through large manufacturing capacity and backward integration
Dec 1, 2019
Enhancing Supply Chain Security for Levetiracetam API
Disclaimer
No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patents Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.
